How Assistance Works
Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience
-
1. Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
-
2. Transfer Prescription to AmeriPharma®
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
-
3. Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
-
4. Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma® Specialty Care has secured $55 million in financial assistance for our patients.
-
5. Nursing Care Coordination If Needed
AmeriPharma® puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
-
6. Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
Ojjaara Introduction and Uses
Ojjaara is a brand-name product. It contains the active ingredient momelotinib, which belongs to the Janus kinase (JAK) inhibitor drug class. No generic versions of this medication are currently available.
Ojjaara is not chemotherapy, but rather a targeted therapy that lowers the activity of the immune system for cancer treatment.
In 2023, the US FDA approved this medication to treat certain forms of myelofibrosis in adults with anemia. Myelofibrosis is a rare cancer that causes scar tissue to form in the bone marrow. As a result, the bone marrow fails to produce enough healthy blood cells, resulting in:
- Shortness of breath and tiredness
- Easy bruising or bleeding
- Recurrent infections
Your liver or spleen may also become enlarged.
Ojjaara Mechanism of Action
Ojjaara is a janus kinase (JAK) inhibitor. Cells inside the bone marrow contain proteins (JAK) that become overactive when you have myelofibrosis. Ojjaara blocks the action of these proteins. In addition, Ojjaara blocks another protein in the liver cells, leading to an increased level of healthy red blood cells.
Ojjaara Dosage
Ojjaara comes as 100 mg, 150 mg, and 200 mg tablets that are taken by mouth.
The recommended dosage is 200 mg orally once daily. Your healthcare provider may prescribe a lower dose, 150 mg orally once daily, if you have severe liver problems.
Before and during treatment with this medication, your healthcare provider will monitor your blood counts and liver function. Moreover, you will be asked to take tests to see if you have active hepatitis B before starting this medication.
Treatment with Ojjaara is long-term and will likely continue as long as it is safe and effective for you. However, if you experience severe side effects or the medication stops working, your healthcare provider may ask you to stop it temporarily or permanently.
Copay and Financial Assistance
AmeriPharma® Specialty Pharmacy alleviates financial burdens for patients and their families
-
Advanced software locates funding sources to match you with top-dollar foundation programs
-
One of our copay assistance specialists will assist with the application process
-
Automatic updates will be sent to you and your physician on the status of the funding
Proper Use, Storage, and Disposal
- Before using this medication, read the instructions on the prescription label carefully. Take your doses exactly as directed.
- If you have any questions, talk to your doctor or pharmacist.
- Swallow the entire tablet; avoid crushing, chewing, or breaking it.
- You may take this medication with or without food.
- Never stop taking this or any medicine without talking to your healthcare provider.
- Store this medication at temperatures between 20°C and 25°C (68°F and 77°F). Storage between 15°C and 30°C (59°F and 86°F) may be allowed for a brief period.
- Store Ojjaara in the original bottle, which contains a desiccant packet that protects the tablets from moisture. Never discard desiccant.
- Replace the cap tightly each time after you take the recommended tablets.
- Dispose of unused or expired medicines following the local requirements. Click HERE to learn how to dispose of unneeded or expired drugs.
Ojjaara Side Effects
Common side effects include:
- Low platelet count
- Bleeding
- Bacterial infection
- Tiredness
- Dizziness
- Diarrhea
- Nausea
- Pain in the back, leg, or arm
- Rash
- Itching
- Blurry vision
Severe side effects
Call your healthcare provider immediately or seek emergency care if you have signs and symptoms of:
- Infections, such as fever, chills, cough, difficulty breathing, diarrhea, vomiting, pain, or a burning sensation when passing urine
- Low platelet counts, such as unexplained bleeding or bruising, or tarry stools
- Liver problems, such as yellow skin or eyes, or pain in the upper right region of your stomach
- Severe skin reactions, such as flu-like symptoms, severe rashes, skin peeling, blistering of the lips, eyes, or mouth
Heart attack or stroke
Though not specifically reported in people taking Ojjaara, heart attack and stroke have been reported in individuals taking a different JAK inhibitor. The risk may be higher among current or past smokers. Seek emergency care if you experience any signs or symptoms of a heart attack or stroke, such as:
- Discomfort in your chest
- Severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw
- Pain or discomfort in your arms, back, neck, jaw, or stomach
- Shortness of breath with or without chest discomfort
- Nausea or vomiting
- Lightheadedness
- Weakness in one part or on one side of your body
- Slurred speech
Blood clots
Blood clots in the arms or legs (deep vein thrombosis or DVT) or in the arteries or lungs (pulmonary embolism or PE) have occurred in people taking JAK inhibitors like Ojjaara. Go to the emergency room immediately if you are experiencing:
- Swelling, pain, or tenderness in one or both legs
- Sudden, unexplained chest pain
- Difficulty breathing
New cancers
Taking JAK inhibitors may increase the risk of getting new cancers. The risk may be higher among current or past smokers. Talk to your healthcare provider about the risk of new cancers while taking this medication.
Insurances Accepted
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Get Started in Minutes
Fill out your information and one of our specialists will call you ASAP.
How Much Can You Save?
Complete this form to save up to 100%!
By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices